Table 5.
Secondary Failure | Arthritis Inefficacy | Patients Intensified | |
---|---|---|---|
Methotrexate added (n) (dose) | 3 (15 mg/week) | 3 (15 mg/week) | 1 (15 mg/week) |
Period between treatments shortened (n) (dose) | 2 (90 mg/8 weeks) 2 (90 mg/10 weeks) |
2 (90 mg/8 weeks) | |
Dose increased from 45 mg to 90 mg | 1 | 5 | 8 |